Skip to main content
search
                   

Lung Cancer Clinical Trials

Hightower is conducting lung cancer clinical trials to provide innovative treatments.

Enroll Now

Breathe Easier

Lung cancer is a complex and serious disease that affects the lungs, often starting in the cells lining the air passages. It is one of the most common types of cancer worldwide and a leading cause of cancer-related deaths.

Lung cancer is prevalent, with a 5-year relative survival rate of 21% for all stages combined. However, with early detection and advanced treatment strategies, survival rates can improve significantly.

Apollo Clinical Trials in Oklahoma City, OK at Hightower focuses on precision medicine and personalized care, aiming to enhance outcomes and quality of life for individuals battling lung cancer. Through innovative research and potential treatment for lung cancer, we are dedicated to changing possibilities in potential treatment for lung cancer.

*Participation in the Clinical Trial is completely free of cost and is your choice.

*To participate, fill out the form, and someone from our research staff will call you to determine your eligibility for the Clinical Research Study.

Study Information

Lung Cancer

Study NameProtocol NumberSponsor
Lung Cancer

APOLLO – P-030101

PrognomIQ

Innovation in Lung Cancer Clinical Trials

The Advanced Precision Observational Lung Living Outcomes (APOLLO) study focuses on advancing precision medicine in lung cancer research. This groundbreaking initiative aims to gather comprehensive data on the molecular and clinical characteristics of lung cancer patients to optimize treatment outcomes.

Hightower clincal approach prioritizes the inclusion of smokers in the study population, recognizing the significant impact of smoking on lung cancer development and progression. By analyzing a diverse range of patient profiles, including smokers, the study seeks to uncover novel insights into lung cancer biology. The study aims to offer personalized treatment strategies for individuals suffering from lung cancer

*All study procedures and study-related treatment, including the investigational drug, are free of cost, and insurance is not required to participate.

*The study doctor will take you through every step of the Clinical Trial before you decide to participate and will answer any questions you have about the study treatment.

What to Expect

If you decide to participate in the Lung Cancer Clinical Trials, by filling out the form above, someone from the study team will contact you to determine your eligibility. The team will go over the study details with you to see if you meet the eligibility criteria for Potential Treatment for Lung Cancer.

You will be invited to the study location for screening if you meet the criteria. The study site will be within a 50-mile radius of your current location. The study doctors will advise you on the duration of the clinical trials for cancer and the implications of your involvement in this research study. We invite you to ask as many questions as you like. After thoroughly explaining everything to the participants, they will be requested to sign an Informed Consent Form. We value transparency between our participants and investigators

*Study-related care is offered at no charge. Expert physicians and healthcare professionals conduct thorough physical exams and assessments. *

Age

≥ 50 to 80 years older

Gender

Male & Female

Condition

Lung Cancer

Current Status

Recruiting

Lung Cancer, a Death Scentence?

Lung cancer is a complex and an aggressive disease that arises from abnormal cell growth in the lungs. Symptoms of lung cancer can vary,

  • Cough
  • Chest pain
  • Shortness of breath
  • Coughing up blood
  • Fatigue
  • Unexplained weight loss

Treatment options for lung cancer may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, or a combination of these approaches, depending on the type and stage of the cancer.

Hightower is conducting clinical trials for the Advanced Precision Observational Lung Living Outcomes so it can offer precise detection and hope for better outcomes and improved quality of life for individuals diagnosed with lung cancer.

Frequently Asked Questions

What is APOLLO for lung cancer?

APOLLO is an advanced precision observational program focused on improving outcomes and personalized care for individuals with lung cancer.

How does APOLLO benefit patients with lung cancer?

APOLLO offers innovative research and tailored treatment approaches, aiming to enhance living outcomes and quality of life for individuals battling lung cancer.

How can I determine if I'm eligible for a clinical trial?

You can determine eligibility for a clinical trial by consulting with your healthcare provider or contacting the research team conducting the trial.

Close Menu